Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Antiviral Nucleoside Inhibitors

Antiviral Nucleoside Inhibitors

Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...

Inhibitors of Viral Protein Synthesis

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...

Drug Discovery: Overview

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...

Drug Administration and Therapy Phases: Overview

Drug Administration and Therapy Phases: Overview

Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...

Biopharmaceutical Factors Influencing Drug Product Design: Overview

Biopharmaceutical Factors Influencing Drug Product Design: Overview

Rational drug product design integrates knowledge of the drug’s physicochemical properties, formulation components, manufacturing techniques, and intended route of administration. Each factor influences the drug’s performance, including how it is released, absorbed, and eliminated in the body.The physicochemical properties of a drug—such as solubility, stability, and particle size—affect its compatibility with excipients and the choice of dosage form. Excipients, though pharmacologically...

Retrovirus Life Cycles

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

[Importance of pharmacogenetics in antiretroviral metabolism and drug-transporters].

Virologie (Montrouge, France)·2022

Same author

[L'usage de papier buvard de type « FTA<sup>TM</sup> Classic » pour la détection et le génotypage du VIH chez des hommes ayant des relations sexuelles avec d'autres hommes à Montréal (Québec, Canada)].

Virologie (Montrouge, France)·2021

Same author

Antiretroviral therapy with integrase inhibitors: more options.

Virologie (Montrouge, France)·2020

Same author

Nonhuman Primates and Humanized Mice for Studies of HIV-1 Integrase Inhibitors: A Review.

Pathogens & immunity·2019

Same author

Dolutegravir Monotherapy of Simian Immunodeficiency Virus-Infected Macaques Selects for Several Patterns of Resistance Mutations with Variable Virological Outcomes.

Journal of virology·2018

Same author

Correction for Anstett et al., "HIV-1 Resistance to Dolutegravir Is Affected by Cellular Histone Acetyltransferase Activity".

Journal of virology·2018

Search research articles

Related Experiment Video

Updated: Jun 28, 2026

Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds

Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds

Published on: October 29, 2015

Perspectives on antiviral drug development.

Mark A Wainberg¹

¹McGill University AIDS Centre, Jewish General Hospital, Montreal, Canada. mark.wainberg@mcgill.ca

Antiviral Research

|October 25, 2008

Summary

The 21st International Conference on Antiviral Research highlighted new drug discovery approaches for viral infections like HIV and influenza. Discussions covered novel cellular targets, drug resistance mechanisms, and optimizing treatment strategies, especially in resource-poor settings.

More Related Videos

High-throughput Screening for Broad-spectrum Chemical Inhibitors of RNA Viruses

High-throughput Screening for Broad-spectrum Chemical Inhibitors of RNA Viruses

Published on: May 5, 2014

Assays for the Identification of Novel Antivirals against Bluetongue Virus

Assays for the Identification of Novel Antivirals against Bluetongue Virus

Published on: October 11, 2013

Related Experiment Videos

Last Updated: Jun 28, 2026

Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds

Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds

Published on: October 29, 2015

High-throughput Screening for Broad-spectrum Chemical Inhibitors of RNA Viruses

High-throughput Screening for Broad-spectrum Chemical Inhibitors of RNA Viruses

Published on: May 5, 2014

Assays for the Identification of Novel Antivirals against Bluetongue Virus

Assays for the Identification of Novel Antivirals against Bluetongue Virus

Published on: October 11, 2013

Area of Science:

Virology
Drug Discovery
Infectious Diseases

Background:

The 21st International Conference on Antiviral Research convened experts to discuss advancements in antiviral research.
The conference covered a broad spectrum of virologic fields, from established treatments to novel therapeutic strategies.

Purpose of the Study:

To present and discuss novel insights and approaches in antiviral drug discovery.
To explore new targets and mechanisms for combating viral infections, including HIV, influenza, hepatitis B, and C.
To address challenges in antiviral therapy, such as drug resistance and accessibility in resource-limited settings.

Main Methods:

The conference featured sessions on chemical synthesis of new antiviral compounds.
Discussions included novel cellular targets (e.g., Apobec3G, LEDGF/p75) for HIV therapy.
Surveys of new targets for hepatitis B and C viruses were presented.

Main Results:

Novel compounds and cellular targets for HIV, influenza, and hepatitis viruses were explored.
Potential mechanisms of drug resistance development by various viruses were discussed, including transmission dynamics and viral fitness.
Key issues in clinical management, such as drug efficacy, toxicity, adherence, and the role of generic drugs, were extensively debated.

Conclusions:

Advancements in antiviral drug discovery are crucial for managing viral infections.
Understanding novel targets and resistance mechanisms is vital for developing effective future therapies.
Addressing practical aspects like drug accessibility and patient adherence is essential for global health outcomes.